1991
DOI: 10.1016/0092-8674(91)90396-g
|View full text |Cite
|
Sign up to set email alerts
|

The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

12
384
1
2

Year Published

1992
1992
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 761 publications
(399 citation statements)
references
References 48 publications
12
384
1
2
Order By: Relevance
“…However, the efficacy of the interference of the L2A or L2B peptides with the binding of the various neurotrophins was not as great as could be expected from previous experiments involving recombinant proteins [39]. Calculation of the inhibition constants for the interaction between the peptides and the neurotrophins yielded K~ values in the range of 2 × 10 -8 M to 1 × 10 -7 M which is at least a factor 20 short of the affinities observed on recombinant receptors as well as on cells ectopically expressing TrkA [9,22] or TrkB [3,31] receptors. This supports our interpretation of the low capacity observed with L2A and L2B affinity columns, i.e.…”
Section: Resultsmentioning
confidence: 55%
See 1 more Smart Citation
“…However, the efficacy of the interference of the L2A or L2B peptides with the binding of the various neurotrophins was not as great as could be expected from previous experiments involving recombinant proteins [39]. Calculation of the inhibition constants for the interaction between the peptides and the neurotrophins yielded K~ values in the range of 2 × 10 -8 M to 1 × 10 -7 M which is at least a factor 20 short of the affinities observed on recombinant receptors as well as on cells ectopically expressing TrkA [9,22] or TrkB [3,31] receptors. This supports our interpretation of the low capacity observed with L2A and L2B affinity columns, i.e.…”
Section: Resultsmentioning
confidence: 55%
“…TrkA is the biologically functional receptor for nerve growth factor (NGF) [9,13], whereas its homolog TrkB binds three different neurotrophins [3,8,16,24,36] namely brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4 (NT-4) [5,14,15,31,32]. The extracellular domains of Trk-type receptors harbor a modular mosaic of potential ligand binding modules, namely two immunoglobulin (Ig)-like domains and an LRM3-cassette consisting of a tandem array of three leucine-rich motifs (LRMs) flanked by cysteine-rich clusters [28].…”
Section: Introductionmentioning
confidence: 99%
“…In contrast, neurotrophin 3 (NT-3) has been reported to inhibit FGF-2-induced Akt activation as well as Akt-induced neuronal proliferation (Jin et al, 2005). We similarly found that the activation of ERK stimulated by co-treatment with FGF-2 and BDNF, which shares similarities to NT-3 (Soppet et al, 1991), was less than additive. It is possible that receptors for these 2 peptides activate pathways that exhibit negative interactions.…”
Section: Discussionmentioning
confidence: 78%
“…Our control using CD4 + Molt4 cells did not reveal induction of tyrosine phosphorylation in response to rgp 120, which is in accordance with the results of Horak et al (1990) forT lymphocytes. Tyrosine phosphorylation of proteins with molecular masses in the range of 110 to 140 kDa has been described to occur after activation of many cell surface receptors on brain cells including receptors for neurotrophic factors (Soppet et al, 1991;Squinto et al, 1991 ), the interleukin-6 receptor (Hibi et al, 1990), and receptors of the integrin family (Kornberg et a/., 1991 ). lt will be of great interest to identify the nature of the receptor complex we found and the tyrosine kinase involved.…”
Section: Discussionmentioning
confidence: 99%